OMO-2
N/A
Report date: 2024/12/11 15:39:36
NME
Base Information
Drug NameOMO-2
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceuticals IncOctimet Oncology Nv
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesShanghai Allist Pharmaceutical Technology Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A